Sun Pharma is an international, integrated, speciality pharmaceutical company with manufacturing units for API and FDF in India, USA, Latin America & Europe. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world. It is backed by 2 state of the art R&D Centers with a team of 600+ scientists for projects in Chemical Synthesis, Clinical Research & formulation development Sun is a leader in niche therapy areas & has strong skills in product development,process chemistry, and manufacturing of complex API, & dosage forms. 

Sales Markets

Western Europe; Eastern Europe; Middle East Region (e.g. UAE); Asia; Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Central/South America; East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity

Manufacturer/Innovator